Multiple Assemblies exist for SMTL entry 8v2f
Crystal structure of IRAK4 kinase domain with compound 9; X-RAY DIFFRACTION 2.09 Å

	SMTL ID 8v2f.1 Ligands N-{2-[(1r,4r)-4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide; CHLORIDE ION; GLYCEROL Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8v2f.2 Ligands N-{2-[(1r,4r)-4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide; CHLORIDE ION; GLYCEROL Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8v2f.3 Ligands N-{2-[(1r,4r)-4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide; CHLORIDE ION; GLYCEROL Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer
	SMTL ID 8v2f.4 Ligands N-{2-[(1r,4r)-4-(hydroxymethyl)cyclohexyl]-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide; GLYCEROL Polypeptides Interleukin-1 receptor-associated kinase 4 Oligo-state monomer